Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 1,946.30
+94.70 (5.11%)
At close: Aug 7, 2025
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
9.74M INR
Profits / Employee
1.54M INR
Market Cap
875.47B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 24,006 | 2,138 | 9.78% |
| Mar 31, 2024 | 21,868 | 935 | 4.47% |
| Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
| Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
| Mar 31, 2021 | 18,573 | 271 | 1.48% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 403,303 |
| HDFC Bank | 214,521 |
| Bharti Airtel | 13,593 |
| Tata Consultancy Services | 607,979 |
| ICICI Bank | 182,665 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Hindustan Unilever | 18,802 |
Lupin News
- 24 days ago - Lupin’s Pithampur Unit-3 gets 3 observations from US FDA after inspection - Business Upturn
- 25 days ago - Lupin launches generic Lotemax ophthalmic suspension in the U.S. market - Business Upturn
- 5 weeks ago - Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market - Business Upturn
- 5 weeks ago - Lupin gets USFDA nod for Loteprednol Etabonate Ophthalmic Gel; Eligible for 180-day generic exclusivity - Business Upturn
- 5 weeks ago - Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market - Business Upturn
- 7 weeks ago - Lupin shares in focus as company signs respiratory drug deal in China with Sino Universal - Business Upturn
- 2 months ago - Lupin gets U.S. FDA tentative approval for Generic Oxcarbazepine ER Tablets - Business Upturn
- 2 months ago - Lupin to present Phase 1 data on LNP7457 cancer drug at ASCO 2025 - Business Upturn